
Boston Scientific Corp (NYSE:BSX) announced on Friday that it has agreed to acquire Nalu Medical Inc., a privately held maker of minimally invasive devices for chronic pain treatment.
The deal includes an upfront cash payment of about $533 million for the remaining equity Boston Scientific does not already own.